CDSCO prohibits / restricts manufacture, sale and distribution of 328 Fixed Dose Combination Drugs (FDCs) by Lexplosion | Sep 18, 2018 | EHS, Healthcare, Pharmaceuticals, statesThe Central Drugs Standard Control Organization (“CDSCO”) has prohibited manufacture, sale or... Read More
Human Immunodeficiency Virus and Acquired Immune Deficiency Syndrome (Prevention and Control) Act, 2017 gains the force of law effective 10.09.2018 by Lexplosion | Sep 14, 2018 | EHS, Healthcare, Pharmaceuticals, statesIn a recent Notification No. S.O. 4715(E), the Central Government has finally given effect to the... Read More
CDSCO issues a list of spurious, adulterated, misbranded, or not of standard quality drugs and devices for the month of August, 2018 by Lexplosion | Sep 14, 2018 | EHS, Healthcare, Pharmaceuticals, statesIn the Safety Alert section of its official website, Central Drugs Standard Control... Read More
The Atomic Energy Regulatory Board (AERB) establishes HELP DESK for providing regulatory support to users of Radiation Facilities by Lexplosion | Sep 13, 2018 | Healthcare, OPS, Pharmaceuticals, statesThe Atomic Energy Regulatory Board has established a Help Desk for providing regulatory support to... Read More
Delhi HC stays Centre’s order preventing manufacture and sale of Oxytocin by Private manufacturers for a period of 1 month i.e. till 31.09.2018 by Lexplosion | Sep 6, 2018 | EHS, Healthcare, Pharmaceuticals, statesThe Delhi High Court has imposed a stay on the Central Government order banning the manufacture... Read More
MOHFW invites comments till 12.10.2018 on the draft ‘Sale of Drugs by e-Pharmacy’ (Part VIB) which it proposes to insert in the Drugs and Cosmetics Rules, 1945 by Lexplosion | Sep 5, 2018 | EHS, Healthcare, Pharmaceuticals, statesIn a notification dated August 28, 2018, the Ministry of Health and Family Welfare (“Ministry”)... Read More
